| $385M | ||
| $350M | ||
| $215M | ||
| $88M | ||
| $82M | ||
| $62M |
Buys | $1,268,000 | 1 | 14 |
Sells | $1,562,652 | 6 | 86 |
| Capper Joseph H | Chief Executive Officer | 1 | $1.27M | 0 | $0 | $1.27M |
| Maersk-Moller Kimberly | Chief Commercial Officer | 0 | $0 | 4 | $496,611 | $-496,611 |
| Hulse William Frank IV | General Counsel and CAO | 0 | $0 | 2 | $1.07M | $-1.07M |
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a semi-permeable protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications; and AMNIOBURN a semi-permeable protective barrier allograft used in the treatment of partial-thickness and full-thickness burns, as well as lead product includes mdHACM, a micronized form of AMNIOFIX, supplied in powder form. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.
Over the last 12 months, insiders at MiMedx Group, Inc. have bought $1.27M and sold $1.56M worth of MiMedx Group, Inc. stock.
On average, over the past 5 years, insiders at MiMedx Group, Inc. have bought $972,110 and sold $1.08M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Capper Joseph H (Chief Executive Officer) — $1.27M.
The last purchase of 200,000 shares for transaction amount of $1.27M was made by Capper Joseph H (Chief Executive Officer) on 2025‑05‑02.
| 2025-11-06 | Sale | Maersk-Moller Kimberly | Chief Commercial Officer | 58,300 0.0382% | $7.42 | $432,329 | -8.94% | |
| 2025-05-02 | Capper Joseph H | Chief Executive Officer | 200,000 0.1361% | $6.34 | $1.27M | +8.23% | ||
| 2025-03-17 | Sale | Maersk-Moller Kimberly | Chief Commercial Officer | 1,759 0.0012% | $8.04 | $14,142 | -14.68% | |
| 2025-03-13 | Sale | Hulse William Frank IV | General Counsel and CAO | 54,596 0.037% | $7.89 | $430,762 | -12.80% | |
| 2025-03-13 | Sale | Maersk-Moller Kimberly | Chief Commercial Officer | 4,106 0.0028% | $7.89 | $32,396 | -12.80% | |
| 2025-03-10 | Sale | Hulse William Frank IV | General Counsel and CAO | 81,446 0.0553% | $7.80 | $635,279 | -11.68% | |
| 2025-02-28 | Sale | Maersk-Moller Kimberly | Chief Commercial Officer | 2,111 0.0015% | $8.40 | $17,743 | -17.92% | |
| 2025-02-13 | Sale | Whitlow Ricci S | Chief Operating Officer | 61,420 0.0422% | $8.28 | $508,558 | -16.43% | |
| 2024-03-13 | Sale | Hulse William Frank IV | General Counsel and CAO | 20,381 0.0139% | $7.95 | $162,029 | -8.30% | |
| 2024-02-20 | Sale | Whitlow Ricci S | Chief Operating Officer | 15,271 0.0131% | $8.01 | $122,351 | -9.33% | |
| 2024-02-16 | Sale | Whitlow Ricci S | Chief Operating Officer | 15,493 0.0133% | $8.07 | $125,075 | -9.55% | |
| 2024-02-15 | Sale | Whitlow Ricci S | Chief Operating Officer | 15,198 0.013% | $8.06 | $122,496 | -11.53% | |
| 2024-02-14 | Sale | Whitlow Ricci S | Chief Operating Officer | 15,845 0.0132% | $8.03 | $127,267 | -9.67% | |
| 2023-11-21 | DOUG RICE | Chief Financial Officer | 5,000 0.0043% | $7.16 | $35,787 | +1.25% | ||
| 2023-06-23 | Capper Joseph H | Chief Executive Officer | 42,025 0.037% | $6.50 | $273,331 | +17.52% | ||
| 2023-06-22 | Capper Joseph H | Chief Executive Officer | 57,975 0.0504% | $6.33 | $367,104 | +19.00% | ||
| 2023-05-16 | Sale | Stein Robert Benjamin | President, Regenerative Med. | 10,365 0.009% | $5.95 | $61,627 | +25.71% | |
| 2023-05-15 | Sale | Stein Robert Benjamin | President, Regenerative Med. | 3,607 0.0032% | $6.15 | $22,170 | +23.93% | |
| 2023-05-10 | Sale | Carlson Peter M | Chief Financial Officer | 5,976 0.0051% | $5.93 | $35,414 | +23.68% | |
| 2023-05-10 | Sale | Hulse William Frank IV | General Counsel and CAO | 5,870 0.005% | $5.93 | $34,786 | +23.68% |
| Capper Joseph H | Chief Executive Officer | 529530 0.3575% | $2.73M | 3 | 0 | +18.26% |
| Hulse William Frank IV | General Counsel and CAO | 440178 0.2972% | $2.27M | 0 | 10 | |
| Maersk-Moller Kimberly | Chief Commercial Officer | 236982 0.16% | $1.22M | 0 | 4 | |
| Okumus Fund Management Ltd. | 10 percent owner | 10533355 7.1122% | $54.35M | 0 | 2 | |
| PETIT PARKER H | Chairman & CEO | 5009121 3.3822% | $25.85M | 9 | 1 | +25.79% |
| WRIGHT TIMOTHY R | Chief Executive Officer | 1711324 1.1555% | $8.83M | 0 | 4 | |
| KOOB CHARLES E | director | 1312306 0.8861% | $6.77M | 3 | 1 | +51.39% |
| MILLER MATTHEW JERGESEN | EVP | 1134397 0.766% | $5.85M | 0 | 5 | |
| Carlson Peter M | Chief Financial Officer | 656435 0.4432% | $3.39M | 0 | 8 | |
| Eichler Kurt M | director | 574576 0.388% | $2.96M | 2 | 0 | |
| Taylor William Charles | President and COO | 467424 0.3156% | $2.41M | 1 | 19 | +61.76% |
| GORLIN STEVE | director | 451857 0.3051% | $2.33M | 29 | 9 | +51.19% |
| Kashyap Rohit | President, WC & Surgical | 430072 0.2904% | $2.22M | 0 | 2 | |
| Whitlow Ricci S | Chief Operating Officer | 403019 0.2721% | $2.08M | 0 | 5 | |
| Stein Robert Benjamin | President, Regenerative Med. | 317803 0.2146% | $1.64M | 0 | 12 | |
| Turner Scott M | SVP, Operations & Procurement | 226643 0.153% | $1.17M | 0 | 3 | |
| MCCAW ROBERTA L | General Counsel and Secretary | 193247 0.1305% | $997,154.52 | 1 | 1 | +85.11% |
| Phelan William Lawrence | Chief Accounting Officer | 184219 0.1244% | $950,570.04 | 0 | 7 | |
| Rooke Andrew K. Jr. | director | 155166 0.1048% | $800,656.56 | 1 | 0 | |
| Graves Mark | SVP & Chief Compliance Officer | 133608 0.0902% | $689,417.28 | 0 | 3 | |
| PAPASAN LARRY W | director | 127320 0.086% | $656,971.20 | 2 | 1 | +51.39% |
| DOUG RICE | Chief Financial Officer | 102200 0.069% | $527,352.00 | 1 | 0 | +1.25% |
| BLESER JOSEPH G | director | 76085 0.0514% | $392,598.60 | 4 | 0 | <0.0001% |
| Culumber Michael J. | Chief Financial Officer | 42000 0.0284% | $216,720.00 | 1 | 0 | +69.23% |
| Haden Alexandra O | General Counsel & Secretary | 40528 0.0274% | $209,124.48 | 1 | 0 | +12.23% |
| Evans Charles Robert | director | 31878 0.0215% | $164,490.48 | 1 | 0 | +6.06% |
| DEWBERRY J TERRY | director | 16666 0.0113% | $85,996.56 | 1 | 0 | |
| YESTON NEIL | director | 5000 0.0034% | $25,800.00 | 1 | 0 | +61.62% |
| Edwards Ken Cleon | former Dir, Pres. & Treas. | 0 0% | $0 | 0 | 1 |
$96,660,103 | 38 | -2.10% | $757.69M | |
$28,907,358 | 35 | 41.41% | $824.08M | |
MiMedx Group, Inc. (MDXG) | $7,598,498 | 27 | 34.68% | $764.21M |
$41,446,394 | 27 | 12.91% | $883.65M | |
$169,638,586 | 22 | 30.82% | $869.02M | |
$24,857,912 | 21 | -35.40% | $716.77M | |
$59,102,045 | 17 | 8.52% | $602.76M | |
$7,254,955 | 14 | 20.70% | $645.28M | |
$133,809,976 | 13 | 31.29% | $839.9M | |
$92,357,691 | 12 | 87.24% | $669.7M | |
$140,543,039 | 10 | 0.77% | $610.12M | |
$11,541,901 | 10 | 8.07% | $737.91M | |
$1,229,070 | 10 | 23.53% | $845.84M | |
$5,794,001 | 10 | 23.26% | $808.71M | |
$38,624,786 | 9 | 1.26% | $720.14M | |
$160,798,946 | 8 | -3.92% | $794.55M | |
$7,234,370 | 3 | -3.34% | $651.27M | |
$33,624,000 | 2 | -50.37% | $771.33M | |
$13,900 | 1 | -39.25% | $801.99M |
| Increased Positions | 102 | +38.64% | 12M | +11.31% |
| Decreased Positions | 110 | -41.67% | 6M | -6% |
| New Positions | 33 | New | 2M | New |
| Sold Out Positions | 26 | Sold Out | 917,163 | Sold Out |
| Total Postitions | 256 | -3.03% | 107M | +5.3% |
| Essex Woodlands Management, Inc. | $182,705.00 | 19.05% | 28.2M | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $73,370.00 | 7.65% | 11.32M | -203,330 | -1.76% | 2025-09-30 |
| Trigran Investments, Inc. | $49,903.00 | 5.2% | 7.7M | -689,430 | -8.22% | 2025-09-30 |
| Vanguard Group Inc | $44,075.00 | 4.6% | 6.8M | -155,611 | -2.24% | 2025-09-30 |
| First Light Asset Management, Llc | $23,671.00 | 2.47% | 3.65M | +2M | +89.52% | 2025-09-30 |
| State Street Corp | $23,293.00 | 2.43% | 3.59M | +128,693 | +3.71% | 2025-09-30 |
| Geode Capital Management, Llc | $18,429.00 | 1.92% | 2.84M | +789 | +0.03% | 2025-09-30 |
| Paradigm Capital Management Inc/Ny | $17,180.00 | 1.79% | 2.65M | -2M | -40.45% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $15,438.00 | 1.61% | 2.38M | +99,084 | +4.34% | 2025-09-30 |
| Cannell Capital Llc | $13,050.00 | 1.36% | 2.01M | -60,086 | -2.9% | 2025-09-30 |